Contrasting hydration changes for ethidium and daunomycin binding to DNA [27]

Journal of the American Chemical Society

Volumn 121, Issue 11, 1999, Pages 2649-2650

  Qu, Xiaogang ^a   Chaires, Jonathan B ^a  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETAINE; DAUNORUBICIN; DOUBLE STRANDED DNA; SUCROSE; TRIETHYLENE GLYCOL;

ANIMAL TISSUE; BINDING AFFINITY; CATTLE; CONTROLLED STUDY; DNA BINDING; DRUG DNA BINDING; DRUG DNA INTERACTION; HYDRATION; LETTER; NONHUMAN; OSMOTIC STRESS; THYMUS;

EID: 0033599521     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja984366b     Document Type: Letter

References (26)

1. (a) Berman, H. M. Curr. Opin. Struct. Biol. 1991, 1, 423-427.
2. (b) Berman, H. M. Curr. Opin. Struct. Biol. 1994, 4, 345-350.
3. (c) Kochoyan, M.; Leroy, J. L. Curr. Opin. Struct. Biol. 1995, 5, 329-333.
4. (d) Westhof, E. Annu. Rev. Biophys. Biophys. Chem. 1988, 17, 125-144.
5. (e) Saenger, W. Annu. Rev. Biophys. Biophys. Chem. 1987, 16, 93-114.
6. (a) Shui, S.; McFail-Isom, L.; Hu, G. G.; Williams, L. D. Biochemistry 1998, 37, 8341-8355.
7. (b) Shui, S.; Shines, C. C.; McFail-Isom, L.; VanDerver, D.; Williams, L. D. Biochemistry 1998, 37, 16877-16887.
8. (a) Schwabe, J. W. R. Curr. Opin. Struct. Biol. 1997, 7, 126-134.
9. (b) Vossen, K. M.; Wolz, R.; Daugherty, M. A.; Fried, M. G. Biochemistry 1997, 36, 11640-11647.
10. (c) Woda, J.; Schneider, B.; Patel, K.; Mistry, K.; Berman, H. M. Biophys. J. 1998, 2170-2177
11. (d) Garner, M. M.; Rau, D. C. EMBO J. 1995, 14, 1257-1263.
12. (e) Robinson, C. R.; Sligar, S. G. J. Mol. Biol. 1993, 234, 302-306.
13. (a) Parsegian, V. A.; Rand, P. R.; Rau, D. C. Methods Enzymol. 1995, 259, 43-94.
14. (b) Robinson, C. R.; Sligar, S. G.. Methods Enzymol. 1995, 259, 395-427.
15. Sidorova, N. Y.; Rau, D. C. Biopolymers 1995, 35, 377-384.
16. Spink, C. H.; Chaires, J. B. Biochemistry 1999, 38, 8, 496-508.
17. 2EDTA, 0.185 M NaCl, pH 7.0) were titrated with increasing drug concentrations using the Aviv, Inc. (Lakewood, NJ) model ATF 105 automated titration spectrofluorometer. Data were fit to the McGhee - von Hippel neighbor exclusion model as described in Correia, J. J.; Chaires, J. B. Methods Enzymol. 1994, 240, 593-614. Solution osmolalities were measured using a Wescor, Inc., model 5520 vapor pressure osmometer.
18. 2EDTA, 0.185 M NaCl, pH 7.0) were titrated with increasing drug concentrations using the Aviv, Inc. (Lakewood, NJ) model ATF 105 automated titration spectrofluorometer. Data were fit to the McGhee - von Hippel neighbor exclusion model as described in Correia, J. J.; Chaires, J. B. Methods Enzymol. 1994, 240, 593-614. Solution osmolalities were measured using a Wescor, Inc., model 5520 vapor pressure osmometer.
19. Straume, M.; Johnson, M. L. Methods Enzymol. 1992, 210, 117-129.
20. (a) Frederick, C. A.; Williams, L. D.; Ughetto, G.; van der Marel, G. A.; van Boom, J. H.; Rich, A.; Wang, A. H.-J. Biochemistry 1990, 29, 2538-2549.
21. (b) Moore, M. H.; Hunter, W. N.; d'Estaintot, B. L.; Kennard, O. J. Mol. Biol. 1989, 206, 693-705.
22. (c) Lipscomb, L. A.; Peek, M. E.; Zhou, F. X.; Bertrand, J. A.; VanDerveer, D.; Williams, L. D. Biochemistry 1994, 33, 3649-3659.
23. Chaires, J. B. Anti-Cancer Drug Des. 1996, 11, 569-580.
24. Chaires, J. B. Biopolymers 1997, 44, 201-215.
25. (a) Kudroashov, E. D.; Bukin, V. A.; Braginskaia, F. I.; Marky, L. A. Biofizika 1998, 43, 40-45.
26. (b) Chalikian, T. V.; Plum, E. G.; Sarvazyan, A. P.; Breslauer, K. J. Biochemistry 1994, 33, 8629-8640.